AbbVie Inc (ABBV)
178.49
+0.61
(+0.34%)
USD |
NYSE |
Mar 18, 16:00
178.49
0.00 (0.00%)
Pre-Market: 05:14
AbbVie Gross Profit Margin (Quarterly): 60.11% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 60.11% |
September 30, 2023 | 53.44% |
June 30, 2023 | 69.42% |
March 31, 2023 | 67.39% |
December 31, 2022 | 72.42% |
September 30, 2022 | 66.10% |
June 30, 2022 | 71.41% |
March 31, 2022 | 70.07% |
December 31, 2021 | 70.98% |
September 30, 2021 | 69.39% |
June 30, 2021 | 67.60% |
March 31, 2021 | 67.62% |
December 31, 2020 | 66.20% |
September 30, 2020 | 60.86% |
June 30, 2020 | 64.40% |
March 31, 2020 | 77.47% |
December 31, 2019 | 76.95% |
September 30, 2019 | 77.36% |
June 30, 2019 | 77.96% |
March 31, 2019 | 78.36% |
December 31, 2018 | 75.65% |
September 30, 2018 | 77.72% |
June 30, 2018 | 76.64% |
March 31, 2018 | 75.71% |
December 31, 2017 | 70.53% |
Date | Value |
---|---|
September 30, 2017 | 76.90% |
June 30, 2017 | 77.98% |
March 31, 2017 | 75.28% |
December 31, 2016 | 77.13% |
September 30, 2016 | 76.62% |
June 30, 2016 | 78.22% |
March 31, 2016 | 77.02% |
December 31, 2015 | 76.95% |
September 30, 2015 | 80.37% |
June 30, 2015 | 83.27% |
March 31, 2015 | 81.31% |
December 31, 2014 | 79.48% |
September 30, 2014 | 78.20% |
June 30, 2014 | 77.41% |
March 31, 2014 | 75.89% |
December 31, 2013 | 74.92% |
September 30, 2013 | 76.56% |
June 30, 2013 | 77.54% |
March 31, 2013 | 73.37% |
December 31, 2012 | 75.70% |
September 30, 2012 | 77.51% |
June 30, 2012 | 76.12% |
March 31, 2012 | 72.30% |
December 31, 2011 | 75.83% |
September 30, 2011 | 73.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
53.44%
Minimum
Sep 2023
78.36%
Maximum
Mar 2019
69.28%
Average
69.40%
Median
Gross Profit Margin (Quarterly) Benchmarks
Amgen Inc | 62.03% |
Gilead Sciences Inc | 70.62% |
Immunogen Inc (DELISTED) | 98.10% |
Johnson & Johnson | 68.23% |
Eli Lilly and Co | 80.88% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 36.83% |
Return on Assets | 3.58% |
Return on Invested Capital | 6.53% |
Profit Margin (Quarterly) | 5.75% |
Operating Margin (Quarterly) | 24.31% |
Return on Net Operating Assets | 4.26% |